|
|
|
|
| LEADER |
01840nam a2200313 u 4500 |
| 001 |
EB001840006 |
| 003 |
EBX01000000000000001003995 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Antiemetics for adults experiencing opioid-induced nausea
|h Elektronische Ressource
|b a review of clinical and cost-effectiveness, benefits, and harms, and guidelines
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
| 246 |
3 |
1 |
|a Anti-emetics for adults experiencing opioid-induced nausea
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2014, 09 April 2014
|
| 300 |
|
|
|a 1 PDF file (44 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Analgesics, Opioid / adverse effects
|
| 653 |
|
|
|a Adult
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Nausea / drug therapy
|
| 653 |
|
|
|a Antiemetics / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
| 500 |
|
|
|a Title from PDF caption title. - "CADTH Rapid Response Service."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK269262
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this report is to retrieve and review existing evidence comparing the efficacy of different antiemetics for treatment of opioid-induced nausea. This report also aims to retrieve and review the evidence regarding the clinical effectiveness, benefits and harms, cost-effectiveness and evidence-based guidelines regarding the use of dimenhydrinate and ondansetron for adult patients experiencing opioid-induced nausea
|